The Foundation for Opioid Response Efforts (FORE) has awarded a grant of $917,027 to Yale University to establish the National Methadone Access and Quality Commission (NMAQC), a new national ...

As more Americans receive treatment for opioid use disorder, that progress is increasingly showing up in the operating room, creating an urgent need to modernize how pain is managed during and after ...

Articles in this report were published with editorial independence. The collection was made possible by the support of WVU Rockefeller Neuroscience Institute. On June 11, 2018, seeking relief from ...

A widely prescribed opioid painkiller showed limited effectiveness and increased risk of negative effects in a new analysis published in BMJ Evidence-Based Medicine. The study examined tramadol, a ...

American primary-care doctors can prescribe methadone for pain—but not for addiction. Meanwhile, their counterparts in Australia, Canada, and the UK have used methadone to treat addiction for over 50 ...

Integrating methadone treatment into primary care settings improves adherence to guideline-concordant health care for opioid use disorder (OUD), according to a study published online Dec. 9 in the ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

NJ gubernatorial candidate Rep. Mikie Sherrill accused Republican opponent Jack Ciattarelli of personally profiting off the opiate crisis in the tensest moment of Wednesday night’s debate. “My ...

The Food and Drug Administration (FDA) issued new draft guidance for the development of non-opioid treatments for chronic pain on Wednesday. The draft, titled Development of Non-Opioid Analgesics for ...

Private equity (PE) acquisitions of opioid treatment programs (OTPs) are growing, with the potential to expand access to methadone, a critical yet underused medication that can cut the risk for ...

Access to medications for opioid use disorder (OUD) in the pharmacy is internationally accepted; however, in the US, methadone treatment for OUD can only be provided by opioid treatment programs (OTPs ...